Se l’incidenza delle valvulopatie è poco rilevante osservando la popolazione in generale, attestandosi al 2,5% circa, fra i pazienti di età superiore a 75 anni la percentuale sale al 10 - 15%.
December 6, 2017
During her presentation titled “Longevity: recent trends and the role for (re)insurers to meet the challenges” at the SCOR Conference 2017, Daria Ossipova, Head of Health and Longevity R&D at SCOR Global Life, add
Presentation of Daria Ossipova about “Longevity: recent trends and the role for (re)insurers to meet the challenges” at the SCOR Annual Conference SCOR.
Biography of Daria Ossipova, Head of Health and Longevity R&D at SCOR Global Life
Paolo De Martin's presentation at the Pacific Insurance Conference 2017
December 4, 2017
SCOR is driven to see its clients succeed and puts all its passion and energy into unlocking value for them.
November 30, 2017
Antimicrobial resistance is a global concern that can jeopardize the treatment of infectious diseases.
November 28, 2017
During his presentation at the SCOR Conference 2017, titled “Transhumanism: the future impact of advanced technologies on society and on the insurance industry”, Laurent Alexandre, CEO of DNA Vision, warned insurers o
November 24, 2017
On 23 November 2017, the Channel Syndicate, SCOR’s Lloyd’s Syndicate, was distinguished twice at the 2017 Insurance Day London Market Awards, during a ceremony at the Hilton London Bankside.
November 22, 2017
On 24 October 2017, SCOR created a Corporate Social Responsibility committee in order to leverage on the pivotal role of boards in terms of ensuring that corporate strategies are consistent with a company’s long-term
November 21, 2017
Autonomous machines are an increasingly present feature in business and in everyday life.
Although the prevalence of heart valve diseases is low in the general population - around 2.5% - it is much higher in patients aged 75 years and older, reaching 10% to 15%.
